Cognition Therapeutics Reports Results for Quarter Ended June 30, 2026

What Happened
Cognition Therapeutics, Inc. (CGTX) filed a Current Report on Form 8-K on August 6, 2026 to announce its financial results for the quarter ended June 30, 2026. The company issued a press release with the results, which is furnished as Exhibit 99.1 to the 8-K; the filing also includes the interactive XBRL cover page (Exhibit 104).

Key Details

• Filing date: August 6, 2026 (Form 8-K).
• Reporting item: Item 2.02 — Results of Operations and Financial Condition.
• Period covered: quarter ended June 30, 2026.
• Exhibit furnished: 99.1 — press release dated August 6, 2026 (104 — Inline XBRL cover page included).

Why It Matters
This 8-K signals that Cognition released its latest quarterly financial results and related disclosures; those figures (revenue, net income/loss, cash position and any guidance) are contained in the press release/exhibits. Investors should review the furnished press release and accompanying SEC filings for the detailed numbers and commentary, since quarterly results can affect valuation, liquidity outlook and near-term investor expectations.